The LifeVest^® wearable cardioverter defibrillator (WCD)  is designed to protect patients at risk of sudden cardiac death (SCD), when a patient’s condition is changing and permanent SCD risk has not been established. This allows a patient’s physician time to assess the patient’s long-term arrhythmic risk and make appropriate plans.

LifeVest is lightweight and easy to wear, allowing patients to return to most of their daily activities, while having the peace of mind that they have protection from SCD. LifeVest is designed to continuously monitor a patient’s heart, detect certain life-threatening rapid heart rhythms, and automatically deliver a treatment shock to restore normal heart rhythm.

LifeVest has been worn by more than one million patients at risk of sudden cardiac death. It is the most used, studied, and proven wearable defibrillator.

LifeVest is designed to detect certain life-threatening rapid heart rhythms and, if needed, automatically deliver a treatment shock to restore normal heart rhythm. Timely defibrillation is the single most important factor to save a patient that is experiencing a rapid, life-threatening arrhythmia. A treatment shock must be delivered within a few minutes after an event to be effective; with each passing minute, a patient’s chances of survival drops 10 percent. LifeVest does not require bystander intervention. In a typical situation, the entire event, from detecting a life-threatening rapid heartbeat to automatically delivering a shock, occurs in about one minute.

The LifeVest WCD does not require bystander intervention. In a typical situation, the entire event, from detecting a life-threatening rapid heartbeat to automatically delivering a shock, occurs in about one minute.

The LifeVest wearable cardioverter defibrillator (WCD) has been worn by more than one million patients at risk of sudden cardiac death.

LifeVest is prescribed by a physician as part of the continuum of care for patients at risk for SCD. LifeVest is used for a wide range of patient conditions or situations, including following a heart attack or before or after bypass surgery or stent placement, as well as for those with cardiomyopathy or congestive heart failure that places them at particular risk for SCD.

LifeVest is covered by most health plans in the United States, including commercial, state, and federal plans. This list summarizes the types of patient conditions and situations that are covered. The patient’s specific health plan coverage policy should be reviewed to determine coverage for prescribing LifeVest.

• Primary prevention (EF ≤35% and MI, NICM, or other DCM), including:
  • After recent MI (Coverage during the 40 day ICD waiting period)
  • Before and after CABG or PTCA (Coverage during the 90 day ICD waiting period)
  • Listed for cardiac transplant
  • Recently diagnosed nonischemic cardiomyopathy (Coverage during the 3 to 9 month ICD waiting period)
  • NYHA Class IV heart failure
  • Terminal disease with life expectancy of less than 1 year
• ICD indications when patient condition delays or prohibits ICD implantation
• ICD explantation

The LifeVest WCD is manufactured by ZOLL^® in its Pittsburgh, PA, facility.

The LifeVest WCD was approved by the FDA in 2001.

Please complete this form. A representative will respond to you shortly

LifeVest is made of lightweight fabric and is easy to wear, allowing patients to return to most common activities of daily life like work, shopping and moderate exercise, while having peace of mind that they have protection from SCD.

The LifeVest WCD is fit to a patient’s body and is worn under regular clothes. Other than the monitor, which is worn in a holster around the waist or on a shoulder strap, there is no evidence that a person is wearing the device.

Patients should wear the LifeVest WCD at all times, including while sleeping. LifeVest should only be removed when a patient is showering or bathing.

Use of an AED requires bystander assistance. The bystander operates the AED by applying the electrodes to the patient and following instructions.

By contrast, the LifeVest WCD requires no bystander intervention. LifeVest can protect patients when they are alone or sleeping. LifeVest is designed to continuously monitor a patient’s heart, detect certain life-threatening rapid heart rhythms, and automatically deliver a treatment shock to restore normal heart rhythm. In addition, LifeVest can offer peace of mind for family members who may worry about awaiting EMS personnel arrival or having to resuscitate a loved one themselves.

LifeVest is available in the United States, Europe, Japan, and several other countries worldwide.

For more information, visit our Ordering and Coverage page.

For LifeVest customer support, technical support, or medical orders, please call 1-800-543-3267, email LifeVest.Info@zoll.com, or complete this form.

Please complete this form to share your contact information. A representative will respond to you shortly.